Article: PP56 Infectious complications of a novel tyrosine kinase inhibitor (ibrutinib) and correlation with immunological markers in patients with malignant hemopathies

€3.03

SKU: product-article-15355 Category: General

Description
Reviews (0)

Description

PP56 Infectious complications of a novel tyrosine kinase inhibitor (ibrutinib) and correlation with immunological markers in patients with malignant hemopathies

Reviews

There are no reviews yet.

Be the first to review “Article: PP56 Infectious complications of a novel tyrosine kinase inhibitor (ibrutinib) and correlation with immunological markers in patients with malignant hemopathies”

You must be logged in to post a review.

Top

Article: PP56 Infectious complications of a novel tyrosine kinase inhibitor (ibrutinib) and correlation with immunological markers in patients with malignant hemopathies

Description

Reviews

Related products

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in breast cancer

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer